Basic Study
Copyright ©The Author(s) 2024.
World J Hepatol. Feb 27, 2024; 16(2): 264-278
Published online Feb 27, 2024. doi: 10.4254/wjh.v16.i2.264
Table 1 List of Reagents
ReagentsCompany
Anti-Lamin B1Hangzhou Hua-An Biotechnology Co., Ltd. (Hangzhou, China)
Anti-α-SMACell Signaling Technology (Danvers, MA, United States)
Anti-NRF1Cell Signaling Technology (Danvers, MA, United States)
Anti-β-actinCell Signaling Technology (Danvers, MA, United States)
Anti-Nrf2Gene Tex Inc. (Alton Parkway lrvine, CA, United States)
Anti-GCLCSanta Cruz (Santa Cruz, CA, United States)
Anti-NQO1Abways Technology, Inc. (Shanghai, China)
Anti-GCLMAbways Technology, Inc. (Shanghai, China)
Anti-PGC1Abcam (Shanghai, China)
Kits for detecting ALT/AST activity Nanjing Jiancheng Bioengineering Institute (Nanjing, China)
Kits for detecting liver hydroxyproline contentNanjing Jiancheng Bioengineering Institute (Nanjing, China)
Kits for detecting hepatic GSHNanjing Jiancheng Bioengineering Institute (Nanjing, China)
Kits for detecting protein carbonylation amountNanjing Jiancheng Bioengineering Institute (Nanjing, China)
Kits for detecting SOD activityNanjing Jiancheng Bioengineering Institute (Nanjing, China)
ATP contentBeyotime Biotech (Shanghai, China)
ELISA kitsRapidBio (West Hills, CA, United States)
mitochondrial DNA extractionSangon Biotech (Shanghai, China)
NE-PER nuclear and cytoplasmic extraction reagentsThermo Fisher Scientific (Waltham, MA, United States)
BCA Protein Assay KitsThermo Fisher Scientific (Waltham, MA, United States)
PrimeScript Master MixTakara (Shiga, Japan)
SYBR Premix Ex TaqTakara (Shiga, Japan)
Trizol reagentLife Technology (Carlsbad, CA, United States)
2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA)Life Technology (Carlsbad, CA, United States)
Table 2 List of Primers for real-time polymerase chain reaction
Target
Primer
Sequence (5'-3')
Col1a1FPTGACTGGAAGAGCGGAGAGT
RPGACGGCTGAGTAGGGAACAC
Col3a1FPATGGGTTTCCCTGGTCCTAA
RPTGCCTTGTAATCCTTGTGGA
Fn1FPAGAACCAGAGGAGGCACAAG
RPCCGTGTAAGGGTCAAAGCAT
Tgfb1FPTGCCCTCTACAACCAACACA
RPGTTGGACAACTGCTCCACCT
Acta2FPGGGAGTAATGGTTGGAATGG
RPGGTGATGATGCCGTGTTCTA
TNFαFPAGGCACTCCCCCAAAAGAT
RPCAGTAGACAGAAGAGCGTGGTG
IL-1βFPAGTTGACGGACCCCAAAAG
RPCTTCTCCACAGCCACAATGA
IL-6FPACAAAGCCAGAGTCCTTCAGAGAG
RPTTGGATGGTCTTGGTCCTTAGCC
iNOSFPCAGGCGGTGCCTATGTCTC
RPCAGCTGGGCTGTACAAACCTT
Nqo1FPCTCGTGGAGACGCTTTACAT
RPCGTTTCTTCCATCCTTCCAG
GclcFPCGGAGGAACGATGTCTGAGT
RPCTGGGGAATGAAGTGATGGT
GclmFPCAATGACCCGAAAGAACTGC
RPCAATGACCCGAAAGAACTGC
ActinFPTTCGTTGCCGGTCCACACCC
RPGCTTTGCACATGCCGGAGCC
18sFPCGCGGTTCTATTTTGTTGGT
RPAGTCGGCATCGTTTATGGTC
ND1FPCTAGCAGAAACAAACCGGGC
RPCCGGCTGCGTATTCTACGTT